The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Mechanisms of action of isoniazid
Open accessAbstract
Summary: For decades after its introduction, the mechanisms of action of the front‐line antituberculosis therapeutic agent isoniazid (INH) remained unclear. Recent developments have shown that peroxidative activation of isoniazid by the mycobacterial enzyme KatG generates reactive species that form adducts with NAD+ and NADP+ that are potent inhibitors of lipid and nucleic acid biosynthetic enzymes. A direct role for some isoniazid‐derived reactive species, such as nitric oxide, in inhibiting mycobacterial metabolic enzymes has also been shown. The concerted effects of these activities – inhibition of cell wall lipid synthesis, depletion of nucleic acid pools and metabolic depression – drive the exquisite potency and selectivity of this agent. To understand INH action and resistance fully, a synthesis of knowledge is required from multiple separate lines of research – including molecular genetic approaches, in vitro biochemical studies and free radical chemistry – which is the intent of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“derivatives (Andries et al., 2005), there remains as much”
BackgroundProtein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153
Spin Trapping: ESR parameters of spin adducts 1474 1528V
Buettner, G. R. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80033-3 · Cited by 1,827
The oxidative environment and protein damage
Davies, M. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.007 · Cited by 1,392
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 1×
“InhA is an enoyl acyl carrier protein reductase (Banerjee et al., 1994; Dessen et al., 1995) involved in the synthesis of mycolic acids, unique and important mycobacterial cell wall lipids, and so its inhibition is in accord with the unique sensitivity of mycobacteria to INH.”
BackgroundThe catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
The biological lifetime of nitric oxide: Implications for the perivascular dynamics of NO and O 2
Thomas, D. D., Liu, X., Kantrow, S. P., & Lancaster, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.355 · Cited by 760
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Recent Developments of Free-Radical Substitutions of Heteroaromatic Bases
Minisci, F., Vismara, E., & Fontana, F. (1989) · HETEROCYCLES · doi:10.3987/rev-88-sr1 · Cited by 452
Wagner, D., Maser, J., Lai, B., Cai, Z., Barry, C. E., Höner zu Bentrup, K., Russell, D. G., & Bermudez, L. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1491 · Cited by 435
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D., & McKinney, J. D. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04078.x · Cited by 342
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Vilchèze, C., Wang, F., Arai, M., Hazbón, M. H., Colangeli, R., Kremer, L., Weisbrod, T. R., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2006) · Nature Medicine · doi:10.1038/nm1466 · Cited by 319
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
S-nitrosylation: spectrum and specificity
Hess, D. T., Matsumoto, A., Nudelman, R., & Stamler, J. S. (2001) · Nature Cell Biology · doi:10.1038/35055152 · Cited by 245
Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase
Bertrand, T., Eady, N. A. J., Jones, J. N., Jesmin, Nagy, J. M., Jamart-Grégoire, B., Raven, E. L., & Brown, K. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402382200 · Cited by 220
Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
The genetics and biochemistry of isoniazid resistance in
Slayden, R. A., & Barry, C. E. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00359-2 · Cited by 205
Rawat, M., Newton, G. L., Ko, M., Martinez, G. J., Fahey, R. C., & Av-Gay, Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3348-3355.2002 · Cited by 194
Manganese: Its Acquisition by and Function in the Lactic Acid Bacteria
Archibald, F. S. (1986) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418609108735 · Cited by 178
Deretic, V., Philipp, W., Dhandayuthapani, S., Mudd, M. H., Curcic, R., Garbe, T., Heym, B., Via, L. E., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17050889.x · Cited by 177
Self-citationNovel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Tseng, H., Srikhanta, Y., McEwan, A. G., & Jennings, M. P. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02460.x · Cited by 162
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Slayden, R. A., Lee, R. E., Jr., & Barry, C. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02145.x · Cited by 153
Master, S. S., Springer, B., Sander, P., Boettger, E. C., Deretic, V. P., & Timmins, G. S. (2002) · Microbiology · doi:10.1099/00221287-148-10-3139 · Cited by 151
Self-citationHeinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Enzymatic activation of hydrazine derivatives. A spin-trapping study.
Sinha, B. K. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33119-3 · Cited by 124
Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid
Zhang, Y., Dhandayuthapani, S., & Deretic, V. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13212 · Cited by 120
Self-citationBuchmeier, N. A., & Fahey, R. C. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00441.x · Cited by 119
Dhandayuthapani, S., Zhang, Y., Mudd, M. H., & Deretic, V. P. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.12.3641-3649.1996 · Cited by 119
Self-citationMarcinkeviciene, J. A., Magliozzo, R. S., & Blanchard, J. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22290 · Cited by 112
Yu, K., Mitchell, C. E., Xing, Y., Magliozzo, R. S., Bloom, B. R., & Chan, J. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0203 · Cited by 112
Mechanism of isoniazid uptake in Mycobacterium tuberculosis
Bardou, F., Raynaud, C., Ramos, C., et al. (1998) · Microbiology · doi:10.1099/00221287-144-9-2539 · Cited by 109
Peroxidase-mediated oxidation of isoniazid
Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C., et al. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.399 · Cited by 94
Timmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3006-3009.2004 · Cited by 90
Self-citationShoeb, H. A., Bowman, B. U., Ottolenghi, A. C., & Merola, A. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.404 · Cited by 89
Catalase-peroxidases (KatG) Exhibit NADH Oxidase Activity
Singh, R., Wiseman, B., Deemagarn, T., Donald, L. J., Duckworth, H. W., Carpena, X., Fita, I., & Loewen, P. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406374200 · Cited by 88
Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., & Meunier, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2137-2144.2002 · Cited by 86
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
Mycobacterium tuberculosisKatG Is a Peroxynitritase
Wengenack, N. L., Jensen, M. P., Rusnak, F. M., & Stern, M. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0358 · Cited by 83
Kremer, L., Dover, L. G., Morbidoni, H. R., Vilchèze, C., Maughan, W. N., Baulard, A. R., Tu, S., Honoré, N., Deretic, V. P., Sacchettini, J. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302435200 · Cited by 81
Self-citationA review of the action of isoniazid.
Youatt, J. (1969) · PubMed · doi:10.1164/arrd.1969.99.5.729 · Cited by 80
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K. E., Hickey, M. J., Barry, C. E., & Stover, C. K. (1999) · BioFactors · doi:10.1002/biof.5520100219 · Cited by 76
Evidence for Isoniazid Oxidation by Oxyferrous Mycobacterial Catalase−Peroxidase
Magliozzo, R. S., & Marcinkeviciene, J. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja962047j · Cited by 68
Ducasse-Cabanot, S., Cohen‐Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Bernadou, J., Daffé, M., Labesse, G., & Quémard, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.242-249.2004 · Cited by 66
VOGT, R. N., Steenkamp, D. J., Zheng, R., & Blanchard, J. S. (2003) · Biochemical Journal · doi:10.1042/bj20030642 · Cited by 62
Deretic, V. P., Pagán-Ramos, E., Zhang, Y., Dhandayuthapani, S., & Via, L. E. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1557 · Cited by 54
Self-citationTimmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.16.5427-5431.2004 · Cited by 49
Self-citationNO and nitrosothiols: spatial confinement and free diffusion
Lancaster, J. R., & Gaston, B. M. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2004 · Cited by 47
Nicotinamide-adenine nucleotides of Mycobacterium tuberculosis H37Rv
Gopinathan, K. P., Sirsi, M., & Ramakrishnan, T. V. (1963) · Biochemical Journal · doi:10.1042/bj0870444 · Cited by 37
Winder, F. G., Collins, P., & Rooney, S. A. (1970) · Biochemical Journal · doi:10.1042/bj1170027pa · Cited by 36
Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J., & Meunier, B. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204637 · Cited by 27
Oxidation of isonicotinic acid hydrazide by the peroxidase system
Zinner, K., Vidigal, C. C. C., Durán, N., & Cilento, G. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90059-5 · Cited by 25
Mutational and expression analysis of tbnat and its response to isoniazid
Sholto-Douglas-Vernon, C., Sandy, J., Victor, T. C., Sim, E., & van Helden, P. D. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46153-0 · Cited by 24
Is the isonicotinoyl radical generated during activation of isoniazid by MnIII-pyrophosphate?
Nguyen, M., Claparols, C., Bernadou, J., & Meunier, B. (2002) · Comptes Rendus Chimie · doi:10.1016/s1631-0748(02)01370-x · Cited by 15
KANG, S., Lee, J. H., Lee, Y., & Kim, C. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.026 · Cited by 15
Inhibitory Effect of NO-Releasing Ciprofloxacin (NCX 976) on Mycobacterium tuberculosis Survival
Ciccone, R., Mariani, F., Cavone, A., Persichini, T., Venturini, G., Ongini, E., Colizzi, V., & Colasanti, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2299-2302.2003 · Cited by 14
Broussy, S., Bernardes‐Génisson, V., Coppel, Y., Quémard, A., Bernadou, J., & Meunier, B. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b417698g · Cited by 10
Cited by
Virulence factors of the Mycobacterium tuberculosis complex
Forrellad, M. A., Klepp, L. I., Gioffré, A., Sabio y García, J., Morbidoni, H. R., Santangelo, M. D. L. P., Cataldi, A. A., & Bigi, F. (2013) · Virulence · doi:10.4161/viru.22329 · Cited by 622
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O'Brien-Simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 439
Colijn, C., Brandes, A., Zucker, J., Lun, D. S., Weiner, B., Farhat, M. R., Cheng, T.-Y., Moody, D. B., Murray, M., & Galagan, J. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000489 · Cited by 430
Metadata
- Authors
- Timmins, G. S., & Deretic, V.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2006-10-24
- Volume
- 62
- Issue
- 5
- Pages
- 1220-1227
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W1987179105
- Cited by
- 421
- References
- 70
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.